Treatment of gastric hemorrhage by pulverized omeprazole and antacid - Concomitant administration via a nasogastric tube

T. Yamaguchi, S. Mukai, E. Kinoshita, Hisakazu Ohtani, Y. Sawada

Research output: Contribution to journalArticle

Abstract

Gastroesophageal reflux (GER) is a common episode in pediatric patients with severe motor and intellectual disabilities (SMID) and occasionally leads to a severe clinical state accompanied with nausea, hematemesis, melena, wheezing, pneumonia, anemia and/or failure to thrive. We report here a case of a 14-year-old male with Lennox syndrome who had been treated with a histamine H2 blocker intravenously or via a nasogastric tube for repeated gastric hemorrhage due to severe GER. Since his gastric hemorrhage became resistant to the H2 blocker, we decided to replace it with a proton pump inhibitor (PPI). Although lansoprazole can be decapsulated for administration via a nasogastric tube, it tends to block fine tubes. The acid-sensitive drug omeprazole, another oral PPI, is commercially available as enteric-coated tablets. Therefore, we pulverized the tablets and administered omeprazole, mixed with a small amount of antacid, via a nasogastric tube. The patient's gastric hemorrhage was dramatically improved. Thus, administration of pulverized omeprazole concomitantly with antacid via a fine nasogastric tube may provide a novel approach for the treatment of chronic GER in pediatric patients with SMID.

Original languageEnglish
Pages (from-to)594-596
Number of pages3
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Volume42
Issue number11
Publication statusPublished - 2004 Nov
Externally publishedYes

Fingerprint

Antacids
Omeprazole
Gastroesophageal Reflux
Stomach
Pediatrics
Proton Pump Inhibitors
Hemorrhage
Intellectual Disability
Enteric-Coated Tablets
Histamine H2 Antagonists
Lansoprazole
Melena
Hematemesis
Failure to Thrive
Respiratory Sounds
Nausea
Tablets
Anemia
Pneumonia
Therapeutics

Keywords

  • Antacid
  • Gastric hemorrhage
  • GERD
  • Nasogastric tube
  • Omeprazole

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology (medical)

Cite this

Treatment of gastric hemorrhage by pulverized omeprazole and antacid - Concomitant administration via a nasogastric tube. / Yamaguchi, T.; Mukai, S.; Kinoshita, E.; Ohtani, Hisakazu; Sawada, Y.

In: International Journal of Clinical Pharmacology and Therapeutics, Vol. 42, No. 11, 11.2004, p. 594-596.

Research output: Contribution to journalArticle

@article{99a4366940724877a7e513d66e1acaf7,
title = "Treatment of gastric hemorrhage by pulverized omeprazole and antacid - Concomitant administration via a nasogastric tube",
abstract = "Gastroesophageal reflux (GER) is a common episode in pediatric patients with severe motor and intellectual disabilities (SMID) and occasionally leads to a severe clinical state accompanied with nausea, hematemesis, melena, wheezing, pneumonia, anemia and/or failure to thrive. We report here a case of a 14-year-old male with Lennox syndrome who had been treated with a histamine H2 blocker intravenously or via a nasogastric tube for repeated gastric hemorrhage due to severe GER. Since his gastric hemorrhage became resistant to the H2 blocker, we decided to replace it with a proton pump inhibitor (PPI). Although lansoprazole can be decapsulated for administration via a nasogastric tube, it tends to block fine tubes. The acid-sensitive drug omeprazole, another oral PPI, is commercially available as enteric-coated tablets. Therefore, we pulverized the tablets and administered omeprazole, mixed with a small amount of antacid, via a nasogastric tube. The patient's gastric hemorrhage was dramatically improved. Thus, administration of pulverized omeprazole concomitantly with antacid via a fine nasogastric tube may provide a novel approach for the treatment of chronic GER in pediatric patients with SMID.",
keywords = "Antacid, Gastric hemorrhage, GERD, Nasogastric tube, Omeprazole",
author = "T. Yamaguchi and S. Mukai and E. Kinoshita and Hisakazu Ohtani and Y. Sawada",
year = "2004",
month = "11",
language = "English",
volume = "42",
pages = "594--596",
journal = "International Journal of Clinical Pharmacology and Therapeutics",
issn = "0946-1965",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "11",

}

TY - JOUR

T1 - Treatment of gastric hemorrhage by pulverized omeprazole and antacid - Concomitant administration via a nasogastric tube

AU - Yamaguchi, T.

AU - Mukai, S.

AU - Kinoshita, E.

AU - Ohtani, Hisakazu

AU - Sawada, Y.

PY - 2004/11

Y1 - 2004/11

N2 - Gastroesophageal reflux (GER) is a common episode in pediatric patients with severe motor and intellectual disabilities (SMID) and occasionally leads to a severe clinical state accompanied with nausea, hematemesis, melena, wheezing, pneumonia, anemia and/or failure to thrive. We report here a case of a 14-year-old male with Lennox syndrome who had been treated with a histamine H2 blocker intravenously or via a nasogastric tube for repeated gastric hemorrhage due to severe GER. Since his gastric hemorrhage became resistant to the H2 blocker, we decided to replace it with a proton pump inhibitor (PPI). Although lansoprazole can be decapsulated for administration via a nasogastric tube, it tends to block fine tubes. The acid-sensitive drug omeprazole, another oral PPI, is commercially available as enteric-coated tablets. Therefore, we pulverized the tablets and administered omeprazole, mixed with a small amount of antacid, via a nasogastric tube. The patient's gastric hemorrhage was dramatically improved. Thus, administration of pulverized omeprazole concomitantly with antacid via a fine nasogastric tube may provide a novel approach for the treatment of chronic GER in pediatric patients with SMID.

AB - Gastroesophageal reflux (GER) is a common episode in pediatric patients with severe motor and intellectual disabilities (SMID) and occasionally leads to a severe clinical state accompanied with nausea, hematemesis, melena, wheezing, pneumonia, anemia and/or failure to thrive. We report here a case of a 14-year-old male with Lennox syndrome who had been treated with a histamine H2 blocker intravenously or via a nasogastric tube for repeated gastric hemorrhage due to severe GER. Since his gastric hemorrhage became resistant to the H2 blocker, we decided to replace it with a proton pump inhibitor (PPI). Although lansoprazole can be decapsulated for administration via a nasogastric tube, it tends to block fine tubes. The acid-sensitive drug omeprazole, another oral PPI, is commercially available as enteric-coated tablets. Therefore, we pulverized the tablets and administered omeprazole, mixed with a small amount of antacid, via a nasogastric tube. The patient's gastric hemorrhage was dramatically improved. Thus, administration of pulverized omeprazole concomitantly with antacid via a fine nasogastric tube may provide a novel approach for the treatment of chronic GER in pediatric patients with SMID.

KW - Antacid

KW - Gastric hemorrhage

KW - GERD

KW - Nasogastric tube

KW - Omeprazole

UR - http://www.scopus.com/inward/record.url?scp=8344289163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8344289163&partnerID=8YFLogxK

M3 - Article

C2 - 15598025

AN - SCOPUS:8344289163

VL - 42

SP - 594

EP - 596

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

SN - 0946-1965

IS - 11

ER -